The Lancet is a weekly peer-reviewed general medical journal. It is one of the world's best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing.
While advance directives are quite common for patients with physical impairments, advance directives for people with mental impairments are controversial. In many countries, including Germany, there are as yet no legal provisions ...
Sep 13, 2023
0
18
If you haven't had lower back pain, it's likely you know someone who has. It affects around 40% of adults in any year, ranging from adolescents to those in later life. While most people recover, around 20% go on to develop ...
Sep 9, 2023
0
11
A new international study led by Queen Mary University of London has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the ...
Sep 5, 2023
0
10
Cedars-Sinai investigators are experienced in the use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with ...
Aug 31, 2023
0
38
Home monitoring of ovulation prior to placing frozen embryos during an IVF process works just as well as hospital checks to determine the best time. In addition, it is more pleasant for women to undergo this in their own ...
Aug 30, 2023
0
31
The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock.
Aug 30, 2023
0
30
A novel antibody-drug conjugate continues to demonstrate superior benefit for patients with HR+, HER2- metastatic breast cancer when compared to standard chemotherapy, according to a new study in The Lancet.
Aug 24, 2023
0
3
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, ...
Aug 23, 2023
0
44
A 65-year-old woman repeatedly seeks medical help for her failing memory. She is first told it's nothing to worry about, then, a year later, that it's "just normal aging." Until finally, the penny drops: "It's Alzheimer's. ...
Aug 23, 2023
0
1
For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...
Aug 22, 2023
0
1
